Sanofi's Auvi-Q

Company: Sanofi ($SNY)
Device: Auvi-Q
Drug delivered: epinephrine

Why it's important: Sanofi makes our list with its January launch of an epinephrine pen that literally talks patients through an emergency injection. In 70% of cases that called for an epeniphrine shot, a patient's or caregiver's unease with the process led to either improper use of the needle or none at all, according to a National Institutes of Health report.

Sanofi's Auvi-Q, a prescription epinephrine injector, instructs the user via a recorded voice to hold the needle in the correct position and counts down as the injection is completed. In developing the cellphone-sized device, Sanofi took into account patients' needs and feedback to make the Auvi-Q a device worth watching.

For more:
Sanofi launches 'talking' emergency epinephrine injector
Sanofi epinephrine device guides users with voice and written instructions
EpiPen update boasts user protection

Sanofi's Auvi-Q

Suggested Articles

The new digital Abilify is a breakthrough for Proteus Digital Health and its patient-tracking products, but not so much for Abilify's maker, Otsuka.

Adamis Pharmaceuticals' EpiPen contender Symjepi, which was rejected last year before the EpiPen havoc, won approval from the FDA.

Researchers in the U.K. have developed a technique to better predict results in liver cancer when drug-laden polymer beads are used to deliver medicines.